
<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rsc="urn:rsc.org" xmlns:art="http://www.rsc.org/schema/rscart38" xml:lang="en" lang="en"><head><!--Google Tag Manager--><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-5HVSFVCN');</script><!--End Google Tag Manager--><title>Highly enantioselective synthesis of both enantiomers of tetrahydroquinoxaline derivatives via Ir-catalyzed asymmetric hydrogenation   - Chemical Science (RSC Publishing) DOI:10.1039/D4SC04222K</title><link rel="canonical" href="https://pubs.rsc.org/en/content/articlehtml/2024/sc/d4sc04222k"/><meta http-equiv="content-type" content="application/xhtml+xml; charset=utf-8"/><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"NRJS-aaa897feae8feeca979","applicationID":"1313546638","transactionName":"M1wANxQFCEcDVU0PWgoWLzUlSyVbDEJcCEEnVgwXFAsKWAdEFgdHEFABDwMMElkO","queueTime":0,"applicationTime":11,"agent":"","atts":""}</script><script type="text/javascript">(window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"1386013924",accountID:"2851366",trustKey:"1029994",xpid:"Vg4CUFVVDhABV1BRAgUBUFcJ",licenseKey:"NRJS-aaa897feae8feeca979",applicationID:"1313546638"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(31),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(32),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),S=t(15),P=t(10),M=t("ee"),C=M.get("tracer"),N=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),P.on(p,r),M.on(d,o),b.on(l,o),P.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),S.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,N(!0)),w[v]("load",i,N(!0)),w[v]("popstate",function(){i(0,U>1)},N(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(32),a=t(31);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(31),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(28),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);return e.protocol&&"data"===e.protocol?void g("Ajax/DataUrl/Excluded"):void(e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this)))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=t(25).recordSupportability,y=NREUM.o.REQ,x=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof x&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;if("string"==typeof i?n=i:"object"==typeof i&&i instanceof y?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n),"data"!==this.params.protocol){var s=(""+(i&&i instanceof y&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}}),u.on("fetch-done",function(t,e){if(this.endTime=a.now(),this.params||(this.params={}),"data"===this.params.protocol)return void g("Ajax/DataUrl/Excluded");this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];if(0===(t||"").indexOf("data:"))return{protocol:"data"};var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(31),s=t(32),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(33);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?l("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&l("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(f&&f<r.startTime)return;var o=[r],i=a({});i&&o.push(i),l("lcp",o)}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||l("cls",[t])})}function a(t){var e=navigator.connection||navigator.mozConnection||navigator.webkitConnection;if(e)return e.type&&(t["net-type"]=e.type),e.effectiveType&&(t["net-etype"]=e.effectiveType),e.rtt&&(t["net-rtt"]=e.rtt),e.downlink&&(t["net-dlink"]=e.downlink),t}function s(t){if(t instanceof w&&!y){var e=Math.round(t.timeStamp),n={type:t.type};a(n),e<=h.now()?n.fid=h.now()-e:e>h.offset&&e<=Date.now()?(e-=h.offset,n.fid=h.now()-e):e=h.now(),y=!0,l("timing",["fi",e,n])}}function c(t){"hidden"===t&&(f=h.now(),l("pageHide",[f]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var f,u,d,p,l=t("handle"),h=t("loader"),m=t(30),v=t(23),w=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){u=new PerformanceObserver(r);try{u.observe({entryTypes:["paint"]})}catch(g){}d=new PerformanceObserver(o);try{d.observe({entryTypes:["largest-contentful-paint"]})}catch(g){}p=new PerformanceObserver(i);try{p.observe({type:"layout-shift",buffered:!0})}catch(g){}}if("addEventListener"in document){var y=!1,x=["click","keydown","mousedown","pointerdown","touchstart"];x.forEach(function(t){document.addEventListener(t,s,v(!1))})}m(c)}},{}],28:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(t)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],29:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],30:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],31:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],32:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],33:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(31),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!T++){var t=O.info=NREUM.info,e=m.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(E,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+O.offset],null,"api"),s("timing",["load",n]);var r=m.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=l+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===m.readyState&&i()}function i(){s("mark",["domContent",a()+O.offset],null,"api")}var a=t(26),s=t("handle"),c=t(31),f=t("ee"),u=t(29),d=t(21),p=t(23),l=d.getConfiguration("ssl")===!1?"http":"https",h=window,m=h.document,v="addEventListener",w="attachEvent",g=h.XMLHttpRequest,y=g&&g.prototype,x=!1;NREUM.o={ST:setTimeout,SI:h.setImmediate,CT:clearTimeout,XHR:g,REQ:h.Request,EV:h.Event,PR:h.Promise,MO:h.MutationObserver};var b=""+location,E={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1216.min.js"},R=g&&y&&y[v]&&!/CriOS/.test(navigator.userAgent),O=e.exports={offset:a.getLastTimestamp(),now:a,origin:b,features:{},xhrWrappable:R,userAgent:u,disabled:x};if(!x){t(20),t(27),m[v]?(m[v]("DOMContentLoaded",i,p(!1)),h[v]("load",r,p(!1))):(m[w]("onreadystatechange",o),h[w]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var T=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(32),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);</script><meta charset="UTF-8"/><meta name="robots" content="index, follow"/><meta name="DC.Creator" content="Ana Xu"/><meta name="DC.Creator" content="Lanxing Ren"/><meta name="DC.Creator" content="Junrong Huang"/><meta name="DC.Creator" content="Yuxiang Zhu"/><meta name="DC.Creator" content="Gang Wang"/><meta name="DC.Creator" content="Chaoyi Li"/><meta name="DC.Creator" content="Yongqiang Sun"/><meta name="DC.Creator" content="Lijuan Song"/><meta name="DC.Creator" content="Hengzhi You"/><meta name="DC.Creator" content="Fen-Er Chen"/><meta name="DC.title" content="Highly enantioselective synthesis of both enantiomers of tetrahydroquinoxaline derivatives via Ir-catalyzed asymmetric hydrogenation  "/><meta name="DC.publisher" content="Royal Society of Chemistry"/><meta name="DC.Date" content="2024/09/25"/><meta name="DC.Identifier" scheme="doi" content="10.1039/D4SC04222K"/><meta name="DC.Language" content="en"/><meta name="citation_title" content="Highly enantioselective synthesis of both enantiomers of tetrahydroquinoxaline derivatives via Ir-catalyzed asymmetric hydrogenation  "/><meta name="citation_author" content="Ana Xu"/><meta name="citation_author" content="Lanxing Ren"/><meta name="citation_author" content="Junrong Huang"/><meta name="citation_author" content="Yuxiang Zhu"/><meta name="citation_author" content="Gang Wang"/><meta name="citation_author" content="Chaoyi Li"/><meta name="citation_author" content="Yongqiang Sun"/><meta name="citation_author" content="Lijuan Song"/><meta name="citation_author" content="Hengzhi You"/><meta name="citation_author" content="Fen-Er Chen"/><meta name="citation_online_date" content="2024/08/23"/><meta name="citation_date" content="2024"/><meta name="citation_journal_title" content="Chemical Science"/><meta name="citation_volume" content="15"/><meta name="citation_issue" content="37"/><meta name="citation_firstpage" content="15243"/><meta name="citation_lastpage" content="15254"/><meta name="citation_doi" content="10.1039/D4SC04222K"/><meta name="citation_pdf_url" content="https://pubs.rsc.org/en/content/articlepdf/2024/sc/d4sc04222k"/><meta name="citation_abstract_html_url" content="https://pubs.rsc.org/en/content/articlelanding/2024/sc/d4sc04222k"/><meta name="citation_fulltext_html_url" content="https://pubs.rsc.org/en/content/articlehtml/2024/sc/d4sc04222k"/><link rel="shortcut icon" href=""/><link type="text/css" rel="stylesheet" href="/content/stylesheets/rschtml2.css?ver=6_2_1"/><link href="https://www.rsc-cdn.org/oxygen/assets/webfonts/fonts.min.css" rel="stylesheet" type="text/css"/><link type="text/css" rel="stylesheet" href="/content/stylesheets/pubs-ui.min.css"/><meta name="viewport" content="width=device-width, initial-scale=1"/><script type="text/javascript" src="/content/scripts/JQueryPlugins.min.js"> </script><script type="text/javascript" src="/content/scripts/GetAnchorText.js"> </script><script type="text/javascript">
    
      $(function() {
      $("table.tgroup tfoot th").attr("colspan", "100");
      $("table.tgroup.rtable").each( function (idx, el) {
      var tw = $(this).width();
      $(this).parent().css("min-width", tw+"px");
      });

      });
      
    </script><!--6_2_1--></head><body class="oxy-ui pubs-ui ahtml-page"><!--Google Tag Manager (noscript)--><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5HVSFVCN" height="0" width="0" style="display:none;visibility:hidden"> </iframe></noscript><!--End Google Tag Manager (noscript)--><div class="viewport autopad"><div class="pnl pnl--drop autopad"><span id="top"/><div id="wrapper"><div class="left_head"><a class="simple" href="/"><img class="rsc-logo" border="0" src="/content/NewImages/royal-society-of-chemistry-logo.png" alt="Royal Society of Chemistry"/></a><br/><span class="btnContainer"><a class="btn btn--tiny btn--primary" target="_blank" title="Link to PDF version" href="/en/content/articlepdf/2024/sc/d4sc04222k">View PDF Version</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to previous article (id:d4sc03630a)" href="/en/content/articlehtml/2024/sc/d4sc03630a" target="_BLANK">Previous Article</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to next article (id:d4sc03235g)" href="/en/content/articlehtml/2024/sc/d4sc03235g" target="_BLANK">Next Article</a></span></div><div class="right_head"><div id="crossmark_container"><div id="crossmark-content"><a id="open-crossmark" href="#" data-target="crossmark"><img style="max-width:100px" id="crossmark-logo" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg" alt="Check for updates"/></a><script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"> </script></div></div><br/><span class="oa"><img src="/content/newimages/open_access_blue.png" alt=""/> Open Access Article<br/><img src="/content/newimages/CCBY-NC.svg" alt=""/>
This Open Access Article is licensed under a <a rel="license" href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons Attribution-Non Commercial 3.0 Unported Licence</a></span></div><div class="article_info"> DOI: <a target="_blank" title="Link to landing page via DOI" href="https://doi.org/10.1039/D4SC04222K">10.1039/D4SC04222K</a>
(Edge Article)
<span class="italic"><a title="Link to journal home page" href="https://doi.org/10.1039/2041-6539/2010">Chem. Sci.</a></span>, 2024, <strong>15</strong>, 15243-15254</div><h1 id="sect175"><span class="title_heading">Highly enantioselective synthesis of both enantiomers of tetrahydroquinoxaline derivatives <span class="italic">via</span> Ir-catalyzed asymmetric hydrogenation<a title="Select to navigate to footnote" href="#fn1">†</a></span></h1><p class="header_text">
      <span class="bold">
        
          
            Ana 
            Xu
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Lanxing 
            Ren
          
        
      </span><sup><span class="sup_ref italic">ae</span></sup>, 
      <span class="bold">
        
          
            Junrong 
            Huang
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Junrong Huang (orcid.org/0000-0001-8647-5418) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0001-8647-5418"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Yuxiang 
            Zhu
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Yuxiang Zhu (orcid.org/0009-0004-1443-3453) in a new window" id="connect-orcid-link" href="http://orcid.org/0009-0004-1443-3453"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">d</span></sup>, 
      <span class="bold">
        
          
            Gang 
            Wang
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Chaoyi 
            Li
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Chaoyi Li (orcid.org/0000-0002-2639-0516) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0002-2639-0516"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Yongqiang 
            Sun
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Lijuan 
            Song
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Lijuan Song (orcid.org/0000-0002-2349-642X) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0002-2349-642X"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*<sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Hengzhi 
            You
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Hengzhi You (orcid.org/0000-0001-8904-5050) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0001-8904-5050"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*<sup><span class="sup_ref italic">ab</span></sup><span class="bold"> and </span>
      <span class="bold">
        
          
            Fen-Er 
            Chen
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Fen-Er Chen (orcid.org/0000-0002-6734-3388) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0002-6734-3388"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*<sup><span class="sup_ref italic">abc</span></sup>
      <br/><a id="affa"><sup><span class="sup_ref italic">a</span></sup></a><span class="italic">School of Science, Harbin Institute of Technology (Shenzhen), Taoyuan Street, Nanshan District, Shenzhen, 518055, China. E-mail: <a href="mailto:songlijuan@hit.edu.cn">songlijuan@hit.edu.cn</a>; <a href="mailto:youhengzhi@hit.edu.cn">youhengzhi@hit.edu.cn</a>; <a href="mailto:rfchen@fudan.edu.cn">rfchen@fudan.edu.cn</a></span>
      <br/><a id="affb"><sup><span class="sup_ref italic">b</span></sup></a><span class="italic">Green Pharmaceutical Engineering Research Center, Harbin Institute of Technology (Shenzhen), Taoyuan Street, Nanshan District, Shenzhen, 518055, China</span>
      <br/><a id="affc"><sup><span class="sup_ref italic">c</span></sup></a><span class="italic">Department of Chemistry, Engineering Center of Catalysis and Synthesis for Chiral Molecules, Fudan University, Shanghai, 200433, China</span>
      <br/><a id="affd"><sup><span class="sup_ref italic">d</span></sup></a><span class="italic">School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107, China</span>
      <br/><a id="affe"><sup><span class="sup_ref italic">e</span></sup></a><span class="italic">School of Chemistry and Chemical Engineering, Hunan Province Key Laboratory for the Design and Application of Actinide Complexes, University of South China, Hengyang City, Hunan Province 421001, P.R. China</span>
    </p><div id="art-admin"><span class="italic bold">Received 
      26th June 2024
    </span><span class="bold italic">, Accepted 20th August 2024</span></div><p class="bold italic">First published on 23rd August 2024</p><hr/><div class="abstract"><h2>Abstract</h2><p>A novel Ir-catalyzed asymmetric hydrogenation protocol for the synthesis of chiral tetrahydroquinoxaline (THQ) derivatives has been developed. By simply adjusting the reaction solvent, both enantiomers of mono-substituted chiral THQs could be selectively obtained in high yields with excellent enantioselectivities (toluene/dioxane: up to 93% yield and 98% ee (<span class="italic">R</span>); EtOH: up to 83% yield and 93% ee (<span class="italic">S</span>)). For 2,3-disubstituted chiral THQs, the <span class="italic">cis</span>-hydrogenation products were obtained with up to 95% yield, 20<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1 dr, and 94% ee. Remarkably, this methodology was also applicable under continuous flow conditions, yielding gram-scale products with comparable yields and enantioselectivities (dioxane: 91% yield and 93% ee (<span class="italic">R</span>); EtOH: 90% yield and 87% ee (<span class="italic">S</span>)). Unlike previously reported Ir-catalyzed asymmetric hydrogenation protocols, this system exhibited a significant improvement as it required no additional additives. Furthermore, comprehensive mechanistic studies including deuterium-labeling experiments, control experiments, kinetic studies, and density functional theory (DFT) calculations were conducted to reveal the underlying mechanism of enantioselectivities for both enantiomers.</p></div><hr/>
    
      <h2 id="sect295"><span class="a_heading">Introduction</span></h2>
      <span>Chiral N-heteroaromatic compounds have received increasing attention in recent decades, mainly because chiral products often form the core structures of numerous bioactive molecules.<a title="Select to navigate to reference" href="#cit1"><sup><span class="sup_ref">1–4</span></sup></a> Typically, a chiral THQ fragment is the key structural unit of cholesterol ester transfer protein (CETP) inhibitors and BD-2 selective BET inhibitors, which are pivotal in treating atherosclerosis and obesity<a title="Select to navigate to references" href="#cit5"><sup><span class="sup_ref">5</span></sup></a> or exhibiting anti-inflammatory activity <span class="italic">in vivo</span>.<a title="Select to navigate to reference" href="#cit6"><sup><span class="sup_ref">6,7</span></sup></a> Asymmetric catalysis, primarily employing chiral transition-metal catalysts, enzymatic catalysts and organocatalysts, is an efficient and powerful strategy to obtain enantiopure molecules.<a title="Select to navigate to reference" href="#cit8"><sup><span class="sup_ref">8–12</span></sup></a> Among them, asymmetric hydrogenation of quinoxalines represents one of the most straightforward and efficient approaches for the synthesis of chiral THQs, and offers excellent atom economy, with almost no waste or byproducts, and thus is a highly sustainable and green strategy.<a title="Select to navigate to reference" href="#cit13"><sup><span class="sup_ref">13–15</span></sup></a> In 2009, both Chan and Vries reported a highly enantioselective iridium-catalyzed asymmetric hydrogenation of alkyl-substituted quinoxalines, employing the diphosphinite ligand (<span class="italic">R</span>)-H<small><sub>8</sub></small>-binapo and the monodentate phosphoramidite ligand (<span class="italic">S</span>)-PipPhos, respectively (<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1A</a>).<a title="Select to navigate to reference" href="#cit16"><sup><span class="sup_ref">16,17</span></sup></a> Recently, Chen reported an Rh-catalyzed asymmetric hydrogenation of alkyl-substituted quinoxalines with a chiral ferrocene-based bisphosphine–thiourea ligand, leading to the production of the desired products with high enantioselectivities (<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1A</a>).<a title="Select to navigate to references" href="#cit18"><sup><span class="sup_ref">18</span></sup></a> Additionally, Fan and Rueping developed a relay catalyzed asymmetric hydrogenation and a transfer hydrogenation approach, respectively, to achieve the reduction of aryl-substituted quinoxalines with good enantioselectivity (<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1B</a>).<a title="Select to navigate to reference" href="#cit19"><sup><span class="sup_ref">19,20</span></sup></a> Furthermore, the more challenging asymmetric hydrogenation system of 2,3-disubstituted quinoxalines has been successfully developed using a chiral cationic ruthenium diamine catalyst or frustrated Lewis pair catalyst to afford the desired products with moderate diastereoselectivities and high enantioselectivities (<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1C</a>).<a title="Select to navigate to reference" href="#cit21"><sup><span class="sup_ref">21,22</span></sup></a> Liu disclosed a novel Mn-catalyzed stereodivergent asymmetric hydrogenation of di-substituted quinoxalines, providing <span class="italic">cis</span>- or <span class="italic">trans</span>-chiral THQs with high yields and good stereoselectivities (<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1C</a>).<a title="Select to navigate to references" href="#cit23"><sup><span class="sup_ref">23</span></sup></a> Despite these advancements, the synthesis of both enantiomers of chiral THQ with the same catalyst has remained challenging until now. Herein, we report the first general and efficient Ir-catalyzed protocol for the synthesis of chiral aryl-substituted THQs. By simply adjusting the reaction solvent, both enantiomers of chiral THQ derivatives could be selectively obtained in high yields with excellent enantioselectivities (toluene/dioxane: up to 93% yield and 98% ee (<span class="italic">R</span>); EtOH: up to 83% yield and 93% ee (<span class="italic">S</span>)). Furthermore, the more challenging 2,3-disubstituted quinoxalines were smoothly hydrogenated with up to 95% yield, 20<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1 dr, and 94% ee. In addition, both enantiomers of chiral THQ could be obtained under continuous flow conditions, yielding gram-scale products without a noticeable decrease in yields and enantioselectivities (dioxane: 91% yield and 93% ee (<span class="italic">R</span>); EtOH: 90% yield and 87% ee (<span class="italic">S</span>)) (<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1D</a>).</span>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch1"><a href="/image/article/2024/SC/d4sc04222k/d4sc04222k-s1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d4sc04222k-s1.tif" src="/image/article/2024/SC/d4sc04222k/d4sc04222k-s1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 1 </b> <span id="sch1"><span class="graphic_title">Asymmetric synthesis of chiral THQs.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
    
    
      <h2 id="sect326"><span class="a_heading">Results and discussion</span></h2>
      <span>Based on our earlier work on Rh-catalyzed asymmetric hydrogenation of alkyl-substituted quinoxalines and quinoxalinones,<a title="Select to navigate to references" href="#cit18"><sup><span class="sup_ref">18</span></sup></a> 2-phenylquinoxaline <strong>1aa′</strong> was chosen as the model substrate for further optimization with an Ir-catalyzed asymmetric hydrogenation reaction (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>). To our delight, the desired product <strong>2a</strong> was obtained with a full conversion and moderate enantioselectivity using ligand <strong>L1</strong> (99% conversion and 65% ee), while only 19% ee was obtained in our earlier work. Encouraged by this promising outcome, we further explored a series of ferrocene-based chiral phosphine ligands. It was observed that ligands <strong>L2–L5</strong>, each containing a thiourea motif, consistently yielded the desired product with high conversions but moderate enantioselectivities (91–99% conversion and 43–65% ee). Pleasingly, ligand <strong>L6</strong>, featuring an <span class="italic">N</span>-methyl substitute, delivered the hydrogenation product <strong>2a</strong> with 99% conversion and an improved ee value of 85%. This observed enhancement could be attributed to the favorable interaction between the catalyst and substrates facilitated by the <span class="italic">N</span>-methyl substitute. In addition, several other ferrocene-based chiral phosphine ligands (<strong>L7–L9</strong>), lacking either the thiourea or the aromatic unit, failed to provide satisfactory enantioselectivity (0–20% ee). This suggests that the presence of both thiourea and aromatic units is indispensable for high conversion and excellent enantioselectivity. Consequently, ligand <strong>L6</strong> emerged as a promising ligand for the asymmetric hydrogenation of quinoxaline derivatives.</span>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch2"><a href="/image/article/2024/SC/d4sc04222k/d4sc04222k-s2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d4sc04222k-s2.tif" src="/image/article/2024/SC/d4sc04222k/d4sc04222k-s2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 2 </b> <span id="sch2"><span class="graphic_title">Ligand screening for the asymmetric hydrogenation of 2-phenylquinoxaline. Reaction conditions: <strong>1aa′</strong> (0.25 mmol) in 2 mL dioxane and <strong>1aa′</strong>/[Ir(cod)Cl]<small><sub>2</sub></small>/ligand ratio = 100/0.5/1; <small><sup><span class="italic">a</span></sup></small><strong>1aa′</strong> hydrochloride/[Rh(cod)Cl]<small><sub>2</sub></small>/ligand ratio = 100/0.5/1 and DCM solvent. Conversions were determined by <small><sup>1</sup></small>H NMR analysis. The ee values were determined by HPLC.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">In an effort to enhance step economy, we aimed to synthesize chiral THQs from simple starting materials.<a title="Select to navigate to references" href="#cit24"><sup><span class="sup_ref">24</span></sup></a> Commercially available <span class="italic">o</span>-phenylene diamine <strong>1a</strong> and 2-bromoacetophenones <strong>1a′</strong> were chosen as the model substrates.<a title="Select to navigate to references" href="#cit25"><sup><span class="sup_ref">25</span></sup></a> These compounds successfully underwent cyclization to generate 2-phenylquinoxaline without the use of additives,<a title="Select to navigate to reference" href="#cit26"><sup><span class="sup_ref">26–28</span></sup></a> which avoids the risk of catalyst poisoning in the subsequent hydrogenation step. Encouragingly, the cyclization reaction proceeded smoothly and, following a simple post-processing step, the hydrogenation reaction was carried out to yield the desired chiral product <strong>2a</strong> with high conversion and good enantioselectivity (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entry 1). Generally, the addition of hydrochloric acid (HCl) accelerates the reaction rate and controls the enantioselectivity in the asymmetric hydrogenation of imines by forming a salt bridge between the catalyst and the substrates.<a title="Select to navigate to reference" href="#cit29"><sup><span class="sup_ref">29–31</span></sup></a> However, as the amount of HCl was reduced, an increase in ee values was observed in this system (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entries 1–3), with the best result obtained in the absence of HCl (99% conversion and 97% ee). Further investigation with other acids and KCl showed that the decreased enantioselectivity was attributed to the acidity rather than the chloride counterion (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entries 4–6). After screening various solvents, no further improvement was observed (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entries 7–13). However, comparable yields and enantioselectivities were achieved in single dioxane and toluene solvents (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entries 7 and 8). Surprisingly, the reversed configuration hydrogenation product (<span class="italic">S</span>)-<strong>2a</strong> was observed in MeOH with 99% conversion and 85% ee (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entries 14). This might be attributed to the participation of alcoholic solvent molecules in the enantiocontrol step. Coincidentally, Zhang's group also observed this interesting phenomenon in asymmetric hydrogenation of quinolines using the strong Brønsted acid HCl or CH<small><sub>3</sub></small>CO<small><sub>2</sub></small>H as the additive.<a title="Select to navigate to references" href="#cit32"><sup><span class="sup_ref">32</span></sup></a> Further screening of other alcoholic solvents and additives, including trifluoroethanol, was performed (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entries 15–19), resulting in a satisfactory conversion and enantioselectivity in ethanol solvent (99% conversion and 89% ee). In addition, this reversed product can also be observed in toluene systems by adding an appropriate amount of ethanol solvent (Table S4<a title="Select to navigate to footnote" href="#fn1">†</a>). The transfer hydrogenation pathway was excluded in the EtOH system because the reaction did not occur in the absence of H<small><sub>2</sub></small> (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entry 20). Notably, high reactivity and good enantioselectivity were maintained even at a molar substrate-to-catalyst (S/C) ratio of up to 1500 (toluene/dioxane) and 1000 (ethanol) (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entries 21–22). Consequently, toluene/dioxane and ethanol were selected as the optimal solvents for the synthesis of (<span class="italic">R</span>)- and (<span class="italic">S</span>)-THQs, respectively.</p>
      
<div class="table_caption"><b>Table 1</b> <span id="tab1">Optimization of reaction conditions for Ir-catalyzed asymmetric hydrogenation of 2-phenylquinoxaline<i><small><sup style="color: red;"><a title="" href="#tab1fna">a</a></sup></small></i></span>
		</div>

          <div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col/><col/><col/><col/><col/><col/></colgroup>
            
            
            
            
            
            
            <thead align="left">
              <tr align="left" valign="bottom">
                <th colspan="6" align="left" valign="bottom" class="border_black">
                  <p align="center"><a href="/image/article/2024/SC/d4sc04222k/d4sc04222k-u1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d4sc04222k-u1.tif" src="/image/article/2024/SC/d4sc04222k/d4sc04222k-u1.gif"/></a></p>
                </th>
              </tr>
              <tr align="left" valign="bottom">
                <th align="left" valign="bottom" class="border_black">Entry</th>
                <th align="left" valign="bottom" class="border_black">Solvent</th>
                <th align="left" valign="bottom" class="border_black">Additive</th>
                <th align="left" valign="bottom" class="border_black">S/C</th>
                <th align="left" valign="bottom" class="border_black">Conv. (%)</th>
                <th align="left" valign="bottom" class="border_black">ee (%)</th>
              </tr>
            </thead>
            <tfoot align="left">
              <tr align="left">
                <th colspan="6">
                  <a id="tab1fna"><span class="tfootnote">a</span></a> <span class="sup_inf">Reaction conditions: <strong>1a</strong> and <strong>1a′</strong> (0.25 mmol) in 1 mL solvent, <strong>1a</strong>/[Ir(cod)Cl]<small><sub>2</sub></small>/ligand ratio = 100/0.5/1, room temperature, 18 h and H<small><sub>2</sub></small> (2 MPa), and Tol/dio = toluene/dioxane.</span>
                  <a id="tab1fnb"><span class="tfootnote">b</span></a> <span class="sup_inf">The reaction temperature was 45 °C.</span>
                  <a id="tab1fnc"><span class="tfootnote">c</span></a> <span class="sup_inf">The reaction temperature was 60 °C.</span>
                  <a id="tab1fnd"><span class="tfootnote">d</span></a> <span class="sup_inf">Additive 0.2 eq. (substrate at 1 equivalent).</span>
                  <a id="tab1fne"><span class="tfootnote">e</span></a> <span class="sup_inf">Without the use of H<small><sub>2</sub></small>. Conversions were determined by <small><sup>1</sup></small>H NMR analysis. The ee values were determined by HPLC.</span>
                </th>
              </tr>
            </tfoot>
            <tbody align="left">
              <tr align="left">
                <td valign="top">1</td>
                <td valign="top">Tol/dio = 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1</td>
                <td valign="top">0.2 eq. HCl</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">99</td>
                <td valign="top">85 (<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">2</td>
                <td valign="top">Tol/dio = 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1</td>
                <td valign="top">0.1 eq. HCl</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">99</td>
                <td valign="top">94 (<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">3</td>
                <td valign="top">Tol/dio = 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1</td>
                <td valign="top">—</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">99</td>
                <td valign="top">97 (<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">4<i><small><sup style="color: red;"><a title="" href="#tab1fnd">d</a></sup></small></i></td>
                <td valign="top">Tol/dio = 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1</td>
                <td valign="top">KCl</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">99</td>
                <td valign="top">97 (<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">5<i><small><sup style="color: red;"><a title="" href="#tab1fnd">d</a></sup></small></i></td>
                <td valign="top">Tol/dio = 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1</td>
                <td valign="top">CF<small><sub>3</sub></small>CO<small><sub>2</sub></small>H</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">99</td>
                <td valign="top">82 (<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">6<i><small><sup style="color: red;"><a title="" href="#tab1fnd">d</a></sup></small></i></td>
                <td valign="top">Tol/dio = 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1</td>
                <td valign="top">CF<small><sub>3</sub></small>SO<small><sub>3</sub></small>H</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">99</td>
                <td valign="top">61 (<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">7</td>
                <td valign="top">Dioxane</td>
                <td valign="top">—</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">99</td>
                <td valign="top">93 (<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">8</td>
                <td valign="top">Toluene</td>
                <td valign="top">—</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">99</td>
                <td valign="top">96 (<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">9</td>
                <td valign="top">CH<small><sub>3</sub></small>CN</td>
                <td valign="top">—</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">73</td>
                <td valign="top">67 (<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">10</td>
                <td valign="top">THF</td>
                <td valign="top">—</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">88</td>
                <td valign="top">59 (<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">11</td>
                <td valign="top">Et<small><sub>2</sub></small>O</td>
                <td valign="top">—</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">34</td>
                <td valign="top">61 (<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">12</td>
                <td valign="top">CHCl<small><sub>3</sub></small></td>
                <td valign="top">—</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">27</td>
                <td valign="top">63 (<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">13</td>
                <td valign="top">DMSO</td>
                <td valign="top">—</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">Trace</td>
                <td valign="top">—</td>
              </tr>
              <tr align="left">
                <td valign="top">14</td>
                <td valign="top">MeOH</td>
                <td valign="top">—</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">99</td>
                <td valign="top">85 (<span class="italic">S</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">15</td>
                <td valign="top">(CH<small><sub>3</sub></small>)<small><sub>2</sub></small>CHCH<small><sub>2</sub></small>OH</td>
                <td valign="top">—</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">99</td>
                <td valign="top">79 (<span class="italic">S</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">16</td>
                <td valign="top">iPrOH</td>
                <td valign="top">—</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">67</td>
                <td valign="top">50 (<span class="italic">S</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">17</td>
                <td valign="top">EtOH</td>
                <td valign="top">—</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">99</td>
                <td valign="top">89 (<span class="italic">S</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">18</td>
                <td valign="top">CF<small><sub>3</sub></small>CO<small><sub>2</sub></small>H</td>
                <td valign="top">—</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">86</td>
                <td valign="top">55 (<span class="italic">S</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">19<i><small><sup style="color: red;"><a title="" href="#tab1fnd">d</a></sup></small></i></td>
                <td valign="top">EtOH</td>
                <td valign="top">CH<small><sub>3</sub></small>CO<small><sub>2</sub></small>H</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">96</td>
                <td valign="top">85 (<span class="italic">S</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">20<i><small><sup style="color: red;"><a title="" href="#tab1fne">e</a></sup></small></i></td>
                <td valign="top">EtOH</td>
                <td valign="top">—</td>
                <td align="char" char="." valign="top">100</td>
                <td valign="top">—</td>
                <td valign="top">—</td>
              </tr>
              <tr align="left">
                <td valign="top">21</td>
                <td valign="top">Tol/dio = 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1</td>
                <td valign="top">—</td>
                <td align="char" char="." valign="top">1500</td>
                <td valign="top">15<i><small><sup style="color: red;"><a title="" href="#tab1fnb">b</a></sup></small></i>/97<i><small><sup style="color: red;"><a title="" href="#tab1fnc">c</a></sup></small></i></td>
                <td valign="top">90<i><small><sup style="color: red;"><a title="" href="#tab1fnb">b</a></sup></small></i>/90<i><small><sup style="color: red;"><a title="" href="#tab1fnc">c</a></sup></small></i> (<span class="italic">R</span>)</td>
              </tr>
              <tr align="left">
                <td valign="top">22</td>
                <td valign="top">EtOH</td>
                <td valign="top">—</td>
                <td align="char" char="." valign="top">1000</td>
                <td valign="top">99</td>
                <td valign="top">81 (<span class="italic">S</span>)</td>
              </tr>
            </tbody>
          </table></div></div>
        <hr class="hrule"/><br/>
      <p class="otherpara">Having established the two optimized reaction conditions, we proceeded to evaluate the scope of the hydrogenation reaction. As shown in <a title="Select to navigate to table" href="#tab2">Table 2</a>, a broad range of both enantiomers of chiral THQs were synthesized with high yields and good to excellent enantioselectivities in both solvent systems. The electron-donating groups introduced onto the C<small><sub>2</sub></small>-phenyl ring were well tolerated in toluene/dioxane and ethanol systems, giving the products <strong>2a–2f</strong> with high yields and excellent enantioselectivities. Interestingly, there was a slight decrease in ee values in the EtOH system when a <span class="italic">meta</span>- or <span class="italic">ortho</span>-methyl substituent was introduced onto the phenyl ring (EtOH system: <strong>2c</strong>, 79% and 81% ee; <strong>2d</strong>, 75% and 87% ee). This might indicate that the methyl substitution possibly affects the transition state of the enantio-determining step, leading to a decrease in ee. To our delight, challenging substituents, including –N(Me)<small><sub>2</sub></small> and –OH, could be well tolerated, despite the fact that heteroatoms could easily interrupt the coordination between the substrate and the catalyst (toluene/dioxane system: <span class="bold">2g</span>, 85% yield and 94% ee, and <span class="bold">2h</span>, 79% yield and 91% ee; EtOH system: <span class="bold">2g</span>, 72% yield and 92% ee, and <span class="bold">2h</span>, 76% yield and 91% ee). Subsequently, the effect of electron-withdrawing groups was investigated, and comparable results were obtained (<strong>2i–2o</strong>). Pleasingly, the enantioselectivity was only affected by the strong electron-withdrawing groups attached, resulting in a slight decrease in ee (<strong>2o</strong>). It is noteworthy that the uncommon <span class="italic">para</span>-ester substituent and pharmaceutically useful CF<small><sub>3</sub></small> substituent<a title="Select to navigate to references" href="#cit33"><sup><span class="sup_ref">33</span></sup></a> were compatible with both solvent systems, affording products <strong>2m</strong> and <strong>2n</strong> with good yield and enantioselectivities. The screening of other aromatic substituents at the C<small><sub>2</sub></small>-position, including biphenyl, naphthyl and thiophene groups (<strong>2p–2r</strong>), led to the desired products in good yields with good to excellent enantioselectivities (toluene/dioxane system: 80–93% yield and 88–97% ee and EtOH system: 76–82% yield and 77–92% ee). Interestingly, the use of secondary alkyl substituents gave the products with comparable results in the toluene/dioxane system (<span class="bold">2s</span>, 88% yield and 94% ee; <span class="bold">2t</span>, 86% yield and 97% ee), while the enantioselectivities in the EtOH system dramatically decreased (EtOH system: <span class="bold">2s</span>, 82% yield and 24% ee; <span class="bold">2t</span>, 75% yield and 30% ee). These results indicate that the aromaticity at the C<small><sub>2</sub></small>-position can potentially play an important role in the enantioselectivity in the EtOH system through π–π interactions between the quinoxaline and the catalyst/ligand. Using more sterically hindered <span class="italic">tert</span>-butyl substituents generated the products <strong>2u</strong> in good yield, but with a much lower ee in both solvent systems. Finally, the effects of substituents at the C<small><sub>6</sub></small>- and C<small><sub>7</sub></small>-positions of the quinoxaline were also evaluated (<strong>2v–2y</strong>), leading to the synthesis of products with good to excellent yields and enantioselectivities, with the exception of (<span class="italic">S</span>)-<strong>2x</strong> in the EtOH system (EtOH system: 78% yield and 56% ee).</p>
      
<div class="table_caption"><b>Table 2</b> <span id="tab2">Substrate scope study for Ir-catalyzed asymmetric hydrogenation of 2-substituted quinoxalines<i><small><sup style="color: red;"><a title="" href="#tab2fna">a</a></sup></small></i></span>
		</div>

          <div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col/></colgroup>
            
            <tfoot align="left">
              <tr align="left">
                <th>
                  <a id="tab2fna"><span class="tfootnote">a</span></a> <span class="sup_inf">Reaction conditions: <strong>1a</strong> and <strong>1a′</strong> (0.25 mmol) in 1 mL solvent, 80 °C, and 15 h. <strong>1a</strong>/[Ir(cod)Cl]<small><sub>2</sub></small>/ligand ratio = 100/0.5/1, room temperature, 18 h and 2 MPa H<small><sub>2</sub></small>.</span>
                  <a id="tab2fnb"><span class="tfootnote">b</span></a> <span class="sup_inf">The 2-phenylquinoxaline intermediate was prepared through a separate procedure. Yields were all isolated yields. The ee values were determined by HPLC.</span>
                </th>
              </tr>
            </tfoot>
            <tbody align="left">
              <tr align="left">
                <td valign="top">
                  <a href="/image/article/2024/SC/d4sc04222k/d4sc04222k-u2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d4sc04222k-u2.tif" src="/image/article/2024/SC/d4sc04222k/d4sc04222k-u2.gif"/></a>
                </td>
              </tr>
            </tbody>
          </table></div></div>
        <hr class="hrule"/><br/>
      <p class="otherpara">Encouraged by the excellent results obtained for the mono-substituted quinoxaline derivatives, we further expanded this methodology to the more challenging 2-aryl-3-methyl quinoxalines (see Table S3<a title="Select to navigate to footnote" href="#fn1">†</a> for optimization details). As shown in <a title="Select to navigate to table" href="#tab3">Table 3</a>, a series of 2,3-disubstituted quinoxalines were smoothly hydrogenated to generate enantiopure <span class="italic">cis</span>-THQs with 77–94% yields, &gt;20<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1 dr, and 80–94% ee. Notably, functional groups such as halides (<strong>3b</strong> and <strong>3c</strong>) and methyl (<strong>3d</strong>) on the quinoxaline aromatic ring were well-tolerated, affording the corresponding hydrogenated products with excellent enantioselectivities (90–94% ee). The substrates bearing an electron-withdrawing group (<strong>3e</strong>) or a strong electron-donating group (<strong>3f</strong>) on the 2-phenyl group proceeded efficiently to produce the desired products with good yields and excellent enantioselectivities. In addition, the substrate with a strong electron-withdrawing group (<strong>3g</strong>) was also tested and the corresponding chiral product was obtained with good yield and moderate enantioselectivity. Finally, replacing methyl with an ethyl substituent at the C<small><sub>3</sub></small>-position (<strong>3h</strong>) led to a slight decrease in reactivity and enantioselectivity, resulting in the product in 77% yield and 80% ee.</p>
      
<div class="table_caption"><b>Table 3</b> <span id="tab3">Substrate scope study for Ir-catalyzed asymmetric hydrogenation of 2,3-disubstituted quinoxalines<i><small><sup style="color: red;"><a title="" href="#tab3fna">a</a></sup></small></i></span>
		</div>

          <div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col/><col/><col/><col/><col/><col/><col/><col/></colgroup>
            
            
            
            
            
            
            
            
            <thead align="left">
              <tr align="left" valign="bottom">
                <th colspan="8" align="left" valign="bottom" class="border_black">
                  <p align="center"><a href="/image/article/2024/SC/d4sc04222k/d4sc04222k-u3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d4sc04222k-u3.tif" src="/image/article/2024/SC/d4sc04222k/d4sc04222k-u3.gif"/></a></p>
                </th>
              </tr>
              <tr align="left" valign="bottom">
                <th align="left" valign="bottom" class="border_black">Entry</th>
                <th align="left" valign="bottom" class="border_black">R</th>
                <th align="left" valign="bottom" class="border_black">R<small><sub>1</sub></small></th>
                <th align="left" valign="bottom" class="border_black">R<small><sub>2</sub></small></th>
                <th align="left" valign="bottom" class="border_black">4</th>
                <th align="left" valign="bottom" class="border_black">Yield (%)</th>
                <th align="left" valign="bottom" class="border_black">
                  <span class="italic">cis</span>/<span class="italic">trans</span></th>
                <th align="left" valign="bottom" class="border_black">ee (%)</th>
              </tr>
            </thead>
            <tfoot align="left">
              <tr align="left">
                <th colspan="8">
                  <a id="tab3fna"><span class="tfootnote">a</span></a> <span class="sup_inf">Reaction conditions: 0.25 mmol substrate <strong>3</strong>, 1 mol% [Ir (COD)Cl]<small><sub>2</sub></small>/<strong>L6</strong>, and (<span class="italic">R</span>)-4-hydroxydinaphtho[2,1-<span class="italic">d</span>:1′,2′-<span class="italic">f</span>][1,3,2]dioxaphosphepine 4-oxide ((<span class="italic">R</span>)-CPA) (2 eq.). Yields were all isolated yields. The ee values were determined by HPLC.</span>
                </th>
              </tr>
            </tfoot>
            <tbody align="left">
              <tr align="left">
                <td valign="top">1</td>
                <td valign="top">H</td>
                <td valign="top">Ph</td>
                <td valign="top">Me</td>
                <td valign="top">
                  <strong>4a</strong>
                </td>
                <td align="char" char="." valign="top">94</td>
                <td valign="top">&gt;20<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1</td>
                <td align="char" char="." valign="top">91</td>
              </tr>
              <tr align="left">
                <td valign="top">2</td>
                <td valign="top">Br</td>
                <td valign="top">Ph</td>
                <td valign="top">Me</td>
                <td valign="top">
                  <strong>4b</strong>
                </td>
                <td align="char" char="." valign="top">90</td>
                <td valign="top">&gt;20<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1</td>
                <td align="char" char="." valign="top">94</td>
              </tr>
              <tr align="left">
                <td valign="top">3</td>
                <td valign="top">F</td>
                <td valign="top">Ph</td>
                <td valign="top">Me</td>
                <td valign="top">
                  <strong>4c</strong>
                </td>
                <td align="char" char="." valign="top">86</td>
                <td valign="top">&gt;20<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1</td>
                <td align="char" char="." valign="top">90</td>
              </tr>
              <tr align="left">
                <td valign="top">4</td>
                <td valign="top">Me</td>
                <td valign="top">Ph</td>
                <td valign="top">Me</td>
                <td valign="top">
                  <strong>4d</strong>
                </td>
                <td align="char" char="." valign="top">82</td>
                <td valign="top">&gt;20<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1</td>
                <td align="char" char="." valign="top">92</td>
              </tr>
              <tr align="left">
                <td valign="top">5</td>
                <td valign="top">H</td>
                <td valign="top">4-Cl-Ph</td>
                <td valign="top">Me</td>
                <td valign="top">
                  <strong>4e</strong>
                </td>
                <td align="char" char="." valign="top">90</td>
                <td valign="top">&gt;20<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1</td>
                <td align="char" char="." valign="top">90</td>
              </tr>
              <tr align="left">
                <td valign="top">6</td>
                <td valign="top">H</td>
                <td valign="top">4-OMe-Ph</td>
                <td valign="top">Me</td>
                <td valign="top">
                  <strong>4f</strong>
                </td>
                <td align="char" char="." valign="top">87</td>
                <td valign="top">&gt;20<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1</td>
                <td align="char" char="." valign="top">92</td>
              </tr>
              <tr align="left">
                <td valign="top">7</td>
                <td valign="top">H</td>
                <td valign="top">4-CF<small><sub>3</sub></small>-Ph</td>
                <td valign="top">Me</td>
                <td valign="top">
                  <strong>4g</strong>
                </td>
                <td align="char" char="." valign="top">91</td>
                <td valign="top">&gt;20<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1</td>
                <td align="char" char="." valign="top">70</td>
              </tr>
              <tr align="left">
                <td valign="top">8</td>
                <td valign="top">H</td>
                <td valign="top">Ph</td>
                <td valign="top">Et</td>
                <td valign="top">
                  <strong>4h</strong>
                </td>
                <td align="char" char="." valign="top">77</td>
                <td valign="top">&gt;20<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1</td>
                <td align="char" char="." valign="top">80</td>
              </tr>
            </tbody>
          </table></div></div>
        <hr class="hrule"/><br/>
      <p class="otherpara">Flow chemistry, characterized by a short residence time, high surface area-to-volume ratio, excellent reproducibility, and ease of scale-up, has emerged as an advantageous approach in organic synthesis.<a title="Select to navigate to reference" href="#cit34"><sup><span class="sup_ref">34–39</span></sup></a> Asymmetric hydrogenation is notably well-suited for flow conditions owing to the ease of pressurization and enhanced safety.<a title="Select to navigate to reference" href="#cit40"><sup><span class="sup_ref">40,41</span></sup></a> In line with our interest in flow chemistry,<a title="Select to navigate to reference" href="#cit42"><sup><span class="sup_ref">42–44</span></sup></a> we successfully applied this methodology under continuous flow conditions. As shown in <a title="Select to navigate to scheme" href="#imgsch3">Scheme 3</a>, we first prepared a solution of substrate <strong>1aa′</strong> and the Ir catalyst. This solution was then pumped into a mixer. Concurrently, hydrogen gas was released through a mass flow controller in another stream, converging with the reaction solution in the mixer. Subsequently, the relative parameters were optimized, including the concentration of substrate, gas velocity, liquid velocity, the pressure of H<small><sub>2</sub></small>, and the residence time (see Table S2<a title="Select to navigate to footnote" href="#fn1">†</a> for optimization details). Under the optimized reaction conditions, the desired products (<span class="italic">R</span>)-<strong>2a</strong> and (<span class="italic">S</span>)-<strong>2a</strong> were obtained with high yields and excellent enantioselectivities (dioxane system: 91% yield and 93% ee (<span class="italic">R</span>); EtOH system: 90% yield and 87% ee (<span class="italic">S</span>)). Surprisingly, we found that the addition of HCl is essential for this transformation in dioxane, which could be due to insufficient mixing of the gas–liquid phase under continuous flow conditions. The use of acid enables the breaking of the aromaticity, thereby facilitating the hydrogenation process. Finally, a gram-scale reaction was conducted in both solvent systems to generate both enantiomers of chiral <strong>2a</strong> with comparable yields and enantioselectivities ((<span class="italic">S</span>)-<strong>2a</strong>, 2.75 g, 90% yield, and 87% ee, over 27 h in the EtOH system; (<span class="italic">R</span>)-<strong>2a</strong>, 2.78 g, 91% yield, and 93% ee, over 60 h in the dioxane system).</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch3"><a href="/image/article/2024/SC/d4sc04222k/d4sc04222k-s3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d4sc04222k-s3.tif" src="/image/article/2024/SC/d4sc04222k/d4sc04222k-s3.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 3 </b> <span id="sch3"><span class="graphic_title">Ir-catalyzed asymmetric hydrogenation of 2-phenylquinoxaline (<strong>1aa′</strong>) under continuous flow conditions. Reaction conditions: (<span class="italic">R</span>)-<strong>2a</strong>: 2-phenylquinoxaline (<strong>1aa′</strong>, 0.05 M) in dioxane, 1.0 mol% [Ir (COD)Cl]<small><sub>2</sub></small>/<strong>L6</strong>, H<small><sub>2</sub></small> (3 MPa), rt, HCl (0.025 eq.), and residence time 11 h. (<span class="italic">S</span>)-<strong>2a</strong>: 2-phenylquinoxaline (<strong>1aa′</strong>, 0.05 M) in EtOH, 1.0 mol% [Ir (COD)Cl]<small><sub>2</sub></small>/<strong>L6</strong>, H<small><sub>2</sub></small> (3 MPa), 45 °C, and residence time 2.7 h. Yields were all isolated yields. The ee values were determined by HPLC.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">To further explore the mechanism of this transformation, a series of isotope-labeling experiments of 2-phenylquinoxaline (<strong>1aa′</strong>) were performed, as shown in <a title="Select to navigate to scheme" href="#imgsch4">Scheme 4a</a>. First, the Ir-catalyzed asymmetric hydrogenation of 2-phenylquinoxaline (<strong>1aa′</strong>) was carried out under 1 MPa D<small><sub>2</sub></small> in the toluene system. It was observed that the hydrogenation product was obtained with 98% and 90% deuterium atoms in the C<small><sub>2</sub></small>- and C<small><sub>3</sub></small>-positions (<a title="Select to navigate to scheme" href="#imgsch4">Scheme 4a</a> (1)). Next, we repeated this reaction under 1 MPa D<small><sub>2</sub></small> in ethanol-d<small><sub>1</sub></small> solvent and the result showed that the deuterium atoms were added in the C<small><sub>2</sub></small>- and C<small><sub>3</sub></small>-positions (<a title="Select to navigate to scheme" href="#imgsch4">Scheme 4a</a> (2)). Furthermore, this hydrogenation reaction was performed at 1 MPa D<small><sub>2</sub></small> in ethanol solvent and found that only a small number of deuterium atoms were detected in the corresponding product (<a title="Select to navigate to scheme" href="#imgsch4">Scheme 4a</a> (3)), which means that the hydrogen atoms were almost all from ethanol in the EtOH reaction system. In contrast, we continued this hydrogenation reaction under 1 MPa H<small><sub>2</sub></small> in ethanol-d<small><sub>1</sub></small> solvent (<a title="Select to navigate to scheme" href="#imgsch4">Scheme 4a</a> (4)). The desired product was isolated with 52% deuterium atoms at the C<small><sub>2</sub></small>-position and some of the deuterium atoms were present in the C<small><sub>3</sub></small>-position (20% and 32%, respectively). These results showed that the hydrogen source in this transformation was derived from hydrogen gas in toluene and dioxane systems, whereas it was predominantly derived from ethanol in the EtOH system. This suggested that the Ir-catalyzed asymmetric hydrogenation of quinoxalines may follow distinct reaction pathways.</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch4"><a href="/image/article/2024/SC/d4sc04222k/d4sc04222k-s4_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d4sc04222k-s4.tif" src="/image/article/2024/SC/d4sc04222k/d4sc04222k-s4.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 4 </b> <span id="sch4"><span class="graphic_title">(a) Deuterium-labeling experiments of <strong>1aa′</strong>; (b) control experiments of various N-heteroaromatic compounds. Conditions A; substrate/[Ir(cod)Cl]<small><sub>2</sub></small>/<strong>L6</strong> = 100/0.5/1 in 2 mL toluene/dioxane = 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1, room temperature, 18 h and 2 MPa H<small><sub>2</sub></small>. Conditions B; substrate/[Ir(cod)Cl]<small><sub>2</sub></small>/<strong>L6</strong> = 100/0.5/1 in 2 mL EtOH, room temperature, 18 h and 2 MPa H<small><sub>2</sub></small>. Yields were all isolated yields. The ee values were determined by HPLC.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">Subsequently, control experiments with various N-heteroaromatic compounds were conducted. As shown in <a title="Select to navigate to scheme" href="#imgsch4">Scheme 4b</a>, re-subjection of the intermediate <strong>5a</strong> under the standard reaction conditions in both solvent systems led to the desired product <strong>6a</strong> with 90% ee and 87% ee, respectively. This suggested that the hydrogenation could be a stepwise process, involving two sequential 3,4- and 1,2-hydrogenation processes. The substrate <strong>5b</strong>, without N<small><sub>4</sub></small>-heteroatoms, also displayed high reactivities and good enantioselectivities in both solvent systems. This result indicated that the Ir–H complexes could directly recognize the unsaturated C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>N bond in the substrate without the aid of the N<small><sub>4</sub></small>-heteroatoms in the second hydrogenation step. Moreover, it was observed that <strong>5c</strong> failed to undergo the anticipated hydrogenation. This lack of reactivity could be attributed to its stronger aromaticity, highlighting the significance of N<small><sub>4</sub></small>-heteroatoms during the first hydrogenation step. As we expected, substrates <strong>5d</strong> and <strong>5e</strong> afforded the products in excellent conversion, but the enantioselectivity of <strong>6e</strong> was not ideal. This observation suggests that the benzene substituent or the appropriate alkyl substituents may be essential in the enantio-determining step. The challenging disubstituent-substrate 2,3-diphenylquinoxaline (<strong>5f</strong>) could not be hydrogenated in this system, which may be attributed to its stronger steric hindrance or aromaticity.</p>
      <p class="otherpara">To gather further evidence for identifying the key intermediates in the asymmetric hydrogenation process, we compared the reactivities of C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>N bonds in different quinoxalines (<a title="Select to navigate to scheme" href="#imgsch5">Scheme 5A</a>). An equimolar solution of <strong>5d</strong> and <strong>1aa′</strong> was treated under the standard hydrogenation conditions in toluene solvent. The result suggested that <strong>5d</strong> rapidly converted to <strong>6d</strong> with 76% conversion in 2 h, while only 45% conversion was observed for <strong>1aa′</strong>. These findings further support the hypothesis that the non-substituted C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>N bond is more readily reduced, suggesting that <strong>5a</strong> can be the key intermediate in the asymmetric hydrogenation of 2-phenylquinoxaline. To investigate the kinetic profile of both enantiomers, the asymmetric hydrogenation of <strong>1aa′</strong> was monitored in both toluene/dioxane and EtOH solvent systems (<a title="Select to navigate to scheme" href="#imgsch5">Scheme 5B</a>). In the toluene/dioxane system, a gradual increase of the conversion rate was observed, along with the slow formation of product (<span class="italic">R</span>)-<strong>2a</strong> in 10 h. The intermediate <strong>5a</strong> reached a maximum yield of 18% after 8 h, after which a rapid second hydrogenation process was observed. These results supported a stepwise hydrogenation process, with selective hydrogenation of the non-substituted C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>N bond occurring first. In contrast, the conversion rate of <strong>1aa′</strong> in the EtOH system was faster compared to that in the toluene/dioxane system, achieving full conversion within 11 h. Surprisingly, the formation of <strong>5a</strong> was scarcely observed during the reaction, likely due to its high reactivity towards hydrogenation in the EtOH system. Consequently, these results indicated that the ethanol solvent was able to activate the substrate, thereby accelerating the hydrogenation process.</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch5"><a href="/image/article/2024/SC/d4sc04222k/d4sc04222k-s5_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d4sc04222k-s5.tif" src="/image/article/2024/SC/d4sc04222k/d4sc04222k-s5.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 5 </b> <span id="sch5"><span class="graphic_title">Mechanistic studies of the asymmetric hydrogenation reaction process.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">To explore whether the intermediate <strong>5a</strong> is prone to disproportionation,<a title="Select to navigate to references" href="#cit20"><sup><span class="sup_ref">20</span></sup></a> we dissolved the intermediate <strong>5a</strong> in toluene and placed it in a glove box for 2 h. The same procedure was applied to another sample, but with the addition of 0.2 equivalents of HCl (<a title="Select to navigate to scheme" href="#imgsch5">Scheme 5C</a>). The above control experiments revealed that intermediate <strong>5a</strong> remained almost unreacted in the absence of HCl. However, it underwent a full conversion with the addition of a catalytic amount of HCl, generating racemates <strong>2a</strong> and <strong>1aa′</strong>. This was consistent with the findings during optimization that the presence of HCl led to a negative effect on the enantioselectivity (see <a title="Select to navigate to table" href="#tab1">Table 1</a>, entries 1–3).</p>
      <p class="otherpara">Density functional theory (DFT) calculations were conducted to explore the mechanism of this process. From literature reports on transition-metal-catalyzed asymmetric hydrogenation, a similar reaction pathway in toluene/dioxane has been calculated (<a title="Select to navigate to scheme" href="#imgsch6">Scheme 6</a>).<a title="Select to navigate to reference" href="#cit45"><sup><span class="sup_ref">45,46</span></sup></a> Initially, oxidative addition of H<small><sub>2</sub></small> to the Ir-complex <strong>A-1</strong><span class="italic">via</span> a barrierless transition state <strong>A-TS1</strong> generates a stable Ir<small><sup>(III)</sup></small> intermediate <strong>A-3</strong> (−5.7 kcal mol<small><sup>−1</sup></small>). Based on the finding that the N<small><sub>4</sub></small> heteroatom is critical in the first hydrogenation step (<a title="Select to navigate to scheme" href="#imgsch4">Scheme 4b</a>) and combining the different reactivities of the two C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>N bonds, four potential sites for hydrogen transfer—N<small><sub>1</sub></small>, C<small><sub>2</sub></small>, C<small><sub>3</sub></small>, and N<small><sub>4</sub></small>—are identified, where the substrate coordinates with iridium <span class="italic">via</span> the N<small><sub>4</sub></small>–Ir bond. Computational results suggest that the hydrogen transferred to the C<small><sub>3</sub></small>-position <span class="italic">via</span><strong>A-TS2-C3</strong> is the most favorable, with the lowest energy barrier of 11.0 kcal mol<small><sup>−1</sup></small>. It is much lower than that of other competing transition states (<strong>A-TS2-N4</strong>, <strong>A-TS2-C2</strong>, and <strong>A-TS2-N1</strong>). The generated intermediate <strong>A-4</strong> then undergoes a second hydrogen transfer to the N<small><sub>4</sub></small>-position through transition state <strong>A-TS3</strong>, with an activation free energy of 16.1 kcal mol<small><sup>−1</sup></small>, which results in the formation of intermediate <strong>A-5</strong>. Next, the semireduction intermediate <strong>5a</strong> can be obtained through rapid dissociation from complex <strong>A-5</strong>. This is in good agreement with the control experiments and kinetic studies shown in <a title="Select to navigate to scheme" href="#imgsch4">Schemes 4b</a> and <a title="Select to navigate to scheme" href="#imgsch5">5B</a>. Meanwhile, another H<small><sub>2</sub></small> molecule could coordinate with complex <strong>A-6</strong> to initiate the second hydrogenation. The hydrogen transfer from <strong>A-7</strong> involves three competing pathways. The most favored pathway occurs through transition state <strong>A-TS4</strong>, with hydrogen transferring to the N<small><sub>4</sub></small>-position. It has an activation free energy of 15.3 kcal mol<small><sup>−1</sup></small>, significantly lower than that of transition states <strong>A-TS4-1</strong> and <strong>A-TS4-2</strong> (−26.6 kcal mol<small><sup>−1</sup></small> and 67.9 kcal mol<small><sup>−1</sup></small>, respectively). The intermediate <strong>A-9</strong> is obtained through a proton transfer between N<small><sub>1</sub></small> and N<small><sub>4</sub></small> positions. According to the result of the control experiment, the Ir–H complexes could directly recognize the unsaturated C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>N bond without the aid of the N<small><sub>4</sub></small>-heteroatoms in the second hydrogenation step, and the transition state <strong>A-TS5OR</strong> or <strong>A-TS5OS</strong> was proposed. The second hydrogen transfer to the C<small><sub>2</sub></small>-position from the Re or Si face <span class="italic">via</span> the transition state <strong>A-TS5OR</strong> or <strong>A-TS5OS</strong> is the enantio-determining step. The favored transition state <strong>A-TS5OR</strong> yields the final <span class="italic">R</span>-products with an energy barrier of 18.8 kcal mol<small><sup>−1</sup></small>, which is significantly lower than that of the <span class="italic">S</span>- transition state (22.0 kcal mol<small><sup>−1</sup></small>). Furthermore, the inner-sphere pathway with the substrate coordination to iridium is calculated (see Scheme S2<a title="Select to navigate to footnote" href="#fn1">†</a> for more details), indicating that the energy barrier of the rate-determining step is 30.2 kcal mol<small><sup>−1</sup></small>, which is much higher than that of this pathway (18.8 kcal mol<small><sup>−1</sup></small>).</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch6"><a href="/image/article/2024/SC/d4sc04222k/d4sc04222k-s6_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d4sc04222k-s6.tif" src="/image/article/2024/SC/d4sc04222k/d4sc04222k-s6.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 6 </b> <span id="sch6"><span class="graphic_title">DFT calculated energy potential surface for the proposed pathway in toluene/dioxane systems. (Ar = 3,5-di-CF<small><sub>3</sub></small>Ph; the phenyl groups on the phosphorus atoms are omitted for clarity; the relative Gibbs energies are labelled in kcal mol<small><sup>−1</sup></small>).</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">It is widely acknowledged that solvent can affect the rate, mechanism, and stereochemistry of the reactions.<a title="Select to navigate to references" href="#cit47"><sup><span class="sup_ref">47</span></sup></a> However, comprehensively illustrating the role of solvents remains challenging.<a title="Select to navigate to reference" href="#cit48"><sup><span class="sup_ref">48,49</span></sup></a> Although Zhang and colleagues have reported the enantiodivergent synthesis of chiral tetrahydroquinoline derivatives using a solvent-dependent enantioselective system, the specific role of the solvent was not thoroughly elucidated.<a title="Select to navigate to references" href="#cit32"><sup><span class="sup_ref">32</span></sup></a> The results of optimization of reaction conditions and kinetic studies indicated that ethanol molecules could participate in the enantiocontrol step to realize reversed enantioselectivity, while activating the substrate in our catalytic system. These suggested that the ethanol molecule functions as a hydrogen-bond donor, which can activate the quinoxaline ring by the formation of a hydrogen bond. Hence, in order to gain insight into this interesting reversed configuration phenomenon, the transition states <strong>TS5OR-ET</strong> and <strong>TS5OS-ET</strong> were proposed to be the enantio-determining step in the EtOH system (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>). To our delight, the calculation suggests that the energy barrier for the formation of the final <span class="italic">S</span>-products <span class="italic">via</span><strong>TS5OS-ET</strong> is 3.6 kcal mol<small><sup>−1</sup></small> lower than that for the <span class="italic">R</span>-product, which is consistent with our experiment. Furthermore, distortion/interaction analysis was conducted for the transition states <strong>A-TS5OR</strong>, <strong>A-TS5OS</strong>, <strong>TS5OR-ET</strong> and <strong>TS5OS-ET</strong> (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>).<a title="Select to navigate to reference" href="#cit50"><sup><span class="sup_ref">50–52</span></sup></a> The complex is divided into 2-phenylquinoxaline <strong>1aa′</strong> and catalyst fragments. The analysis suggests that the interaction energy between the catalyst and substrate controls the enantio-selectivity. The interaction energy of <strong>A-TS5OR</strong> is 9.5 kcal mol<small><sup>−1</sup></small> higher than that of <strong>A-TS5OS</strong>, which can be attributed to the favorable π–π interaction between the substrate and ligand (the distance between two benzene rings in <strong>A-TS5OR</strong> and <strong>A-TS5OS</strong> is 3.75 Å and 4.66 Å, respectively). This is the origin of the enantioselectivity in the toluene/dioxane system. In contrast, the interaction energy of <strong>TS5OS-ET</strong> is 6.6 kcal mol<small><sup>−1</sup></small> higher than that of <strong>TS5OR-ET</strong> in the EtOH system, owing to the more favorable face-to-face interactions. Stronger interactions between the benzene ring on the substrate and the trifluoromethyl-substituted benzene ring on the ligand (distance of 3.48 Å), as well as between the benzene ring on the substrate and benzene ring on the ligand (distance of 4.72 Å), are found in <strong>TS5OS-ET</strong>. In addition, hydrogen bonding interactions between the substrate and ethanol in <strong>TS5OS-ET</strong> contribute to the lower energy barrier, as indicated by the O⋯H distance of 1.79 Å and Cl⋯H distance of 2.20 Å. Taken together, π–π interactions and hydrogen bonding interactions make <strong>TS5OS-ET</strong> significantly more stable than <strong>TS5OR-ET</strong>, which accounts for the origin of the enantioselectivity in the EtOH system. Especially, the 2-phenyl substituent on the substrate is essential for the high enantioselectivity in the EtOH system. The absence of the 2-phenyl substituent afforded the products with poor ee values (<a title="Select to navigate to table" href="#tab2">Table 2</a>, <strong>2s</strong> and <strong>2t</strong>).</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig1"><a href="/image/article/2024/SC/d4sc04222k/d4sc04222k-f1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d4sc04222k-f1.tif" src="/image/article/2024/SC/d4sc04222k/d4sc04222k-f1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 1 </b> <span id="fig1"><span class="graphic_title">Distortion–interaction analysis method in the enantio-determining step for the single-point energy calculations; the relative Gibbs energies are labeled in kcal mol<small><sup>−1</sup></small>.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
    
    
      <h2 id="sect1007"><span class="a_heading">Conclusion</span></h2>
      <span>In conclusion, we have developed a novel Ir-catalyzed asymmetric hydrogenation method for the synthesis of chiral tetrahydroquinoxaline under mild and green conditions. Both enantiomers of chiral THQs could be efficiently obtained by adjusting the reaction solvent with excellent yields and enantioselectivities. Pleasingly, this methodology shows great tolerance to a board range of substrates, including 2-substituted and 2,3-disubstituted quinoxalines. Notably, this methodology has been successfully applied under continuous flow conditions, enabling the gram-scale synthesis of enantiopure THQs in both solvent systems. Mechanistic studies, including deuterium labeling experiments, control experiments, kinetic experiments and DFT calculations, were conducted. These studies revealed that the non-covalent π–π and O–H interactions between the chiral catalyst, solvent and substrates are essential for controlling the enantioselectivity. It represents a valuable advance in solvent-controlled enantioselectivity synthesis for transition-metal-catalyzed asymmetric hydrogenation reactions.</span>
    
    
      <h2 id="sect1010"><span class="a_heading">Data availability</span></h2>
      <span>The data supporting this article have been included as part of the ESI.<a title="Select to navigate to footnote" href="#fn1">†</a></span>
    
    
      <h2 id="sect1014"><span class="a_heading">Author contributions</span></h2>
      <span>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</span>
    
    
      <h2 id="sect1017"><span class="a_heading">Conflicts of interest</span></h2>
      <span>There are no conflicts to declare.</span>
    
  
    <h2 id="sect1021"><span class="a_heading">Acknowledgements</span></h2>
      <span>This work was supported by the Shenzhen Science and Technology Research Fund No. JSGG20201103153807021; GXWD20220811173736002; KCXFZ20230731094904009. We are also grateful to the Natural Science Foundation of Guangdong Province (No. 2021A1515110366; No. 2022A1515011859), National Natural Science Foundation of China (No. 22302048; No. 82204231; No. 22203023), Shenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application, and Shenzhen Bay Laboratory Supercomputing Center. We appreciate the guidance and insights provided by Professor Xu-Mu Zhang.</span>
    
    <span id="sect1023"><h2 id="sect1020"><span class="a_heading">Notes and references</span></h2></span><ol type="1">
      <li><span id="cit1">R. D. Taylor, M. MacCoss and A. D. G. Lawson, Rings in Drugs, <span class="italic">J. Med. Chem.</span>, 2014, <span class="bold">57</span>(14), 5845–5859 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jm4017625" title="DOI Link to resource 10.1021/jm4017625">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCntbc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24471928%5Buid%5D" title="PubMed Link to resource 24471928">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/1_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit2">J. Wen, X. Fan, R. Tan, H.-C. Chien, Q. Zhou, L. W. Chung and X. Zhang, Brønsted-Acid-Promoted Rh-Catalyzed Asymmetric Hydrogenation of N-Unprotected Indoles: A Cocatalysis of Transition Metal and Anion Binding<span class="bold">,</span>, <span class="italic">Org. Lett.</span>, 2018, <span class="bold">20</span>(8), 2143–2147 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.8b00312" title="DOI Link to resource 10.1021/acs.orglett.8b00312">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXmsVers7s%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29600702%5Buid%5D" title="PubMed Link to resource 29600702">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/2_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit3">A. N. Kim and B. M. Stoltz, Recent Advances in Homogeneous Catalysts for the Asymmetric Hydrogenation of Heteroarenes, <span class="italic">ACS Catal.</span>, 2020, <span class="bold">10</span>, 13834–13851 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acscatal.0c03958" title="DOI Link to resource 10.1021/acscatal.0c03958">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXit12ntb3M" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=34567830%5Buid%5D" title="PubMed Link to resource 34567830">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/3_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit4">S. Wang, C. Xie, Y. Zhu, G. Zi, Z. Zhang and G. Hou, Enantioselective Synthesis of Chiral Cyclic Hydrazines by Ni-Catalyzed Asymmetric Hydrogenation<span class="bold">,</span>, <span class="italic">Org. Lett.</span>, 2023, <span class="bold">25</span>(20), 3644–3648 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.3c01009" title="DOI Link to resource 10.1021/acs.orglett.3c01009">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3sXhtVSgtLzE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=37184220%5Buid%5D" title="PubMed Link to resource 37184220">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/4_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit5">
          G. Chang; M. T. Didiuk; J. I. Finneman; R. S. Garigipati; R. M. Kelley, D. A. Perry,; R. B. Ruggeri; B. M. Bechle, Preparation of 1,2,4-Substituted 1,2,3,4-Tetrahydro-and 1,2-Dihydro-Quinoline and 1,2,3,4-Tetrahydro-Quinoxaline Derivatives as Cetp Inhibitors for the Treatment of Atherosclerosis and Obesity, <span class="italic">WIPO Pat.</span>, WO2004085401A1,  2004 <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/5_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit6">R. P. Law, S. J. Atkinson, P. Bamborough, C.-w. Chung, E. H. Demont, L. J. Gordon, M. Lindon, R. K. Prinjha, A. J. B. Watson and D. J. Hirst, Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (Bet) Inhibitors with Selectivity for the Second Bromodomain, <span class="italic">J. Med. Chem.</span>, 2018, <span class="bold">61</span>(10), 4317–4334 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.jmedchem.7b01666" title="DOI Link to resource 10.1021/acs.jmedchem.7b01666">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXns1Sjtbc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29656650%5Buid%5D" title="PubMed Link to resource 29656650">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/6_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit7">
          A. Ansari; S. J. Jeffries; P. Shah; C. Zhang, Methods and Compounds for the Treatment of Genetic Disease, <span class="italic">WIPO Pat.</span>, WO2021158707A1,  2021 <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/7_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit8">F. H. Zhang, F. J. Zhang, L. Li Mao, J. H. Xie and Q. L. Zhou, Enantioselective Hydrogenation of Dialkyl Ketones, <span class="italic">Nat. Catal.</span>, 2020, <span class="bold">3</span>, 621–627 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s41929-020-0474-5" title="DOI Link to resource 10.1038/s41929-020-0474-5">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXhs1OqsbnE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/8_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit9">R. A. A. Abdine, G. Hedouin, F. Colobert and J. Wencel-Delord, Metal-Catalyzed Asymmetric Hydrogenation of C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>N Bonds, <span class="italic">ACS Catal.</span>, 2020, <span class="bold">11</span>, 215–247 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acscatal.0c03353" title="DOI Link to resource 10.1021/acscatal.0c03353">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/9_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit10">Y. H. Hu, Z. F. Zhang, Y. G. Liu and W. B. Zhang, Cobalt-Catalyzed Chemo- and Enantioselective Hydrogenation of Conjugated Enynes, <span class="italic">Angew. Chem., Int. Ed.</span>, 2021, <span class="bold">60</span>, 16989–16993 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.202106566" title="DOI Link to resource 10.1002/anie.202106566">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXhsVKls7jK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=34062038%5Buid%5D" title="PubMed Link to resource 34062038">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/10_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit11">R. Gunasekar, R. L. Goodyear, P. I. Silvestri and L. J. Xiao, Recent Developments in Enantio- and Diastereoselective Hydrogenation of N -Heteroaromatic Compounds, <span class="italic">Org. Biomol. Chem.</span>, 2022, <span class="bold">20</span>, 1794–1827 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D1OB02331D&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D1OB02331D">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/11_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit12">G. Liu, L. Zheng, K. Tian, H. Wang, L. Wa Chung, X. Zhang and X.-Q. Dong, Ir-Catalyzed Asymmetric Hydrogenation of Unprotected Indoles: Scope Investigations and Mechanistic Studies, <span class="italic">CCS Chem.</span>, 2023, <span class="bold">5</span>(6), 1398–1410 <a target="_blank" class="DOILink" href="https://doi.org/10.31635/ccschem.022.202101643" title="DOI Link to resource 10.31635/ccschem.022.202101643">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3sXhsVags77E" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/12_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit13">D.-S. Wang, Q.-A. Chen, S.-M. Lu and Y.-G. Zhou, Asymmetric Hydrogenation of Heteroarenes and Arenes, <span class="italic">Chem. Rev.</span>, 2011, <span class="bold">112</span>(4), 2557–2590 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cr200328h" title="DOI Link to resource 10.1021/cr200328h">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22098109%5Buid%5D" title="PubMed Link to resource 22098109">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/13_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit14">M. P. Wiesenfeldt, Z. Nairoukh, T. Dalton and F. Glorius, Selective Arene Hydrogenation for Direct Access to Saturated Carbo- and Heterocycles, <span class="italic">Angew. Chem., Int. Ed.</span>, 2019, <span class="bold">58</span>(31), 10460–10476 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201814471" title="DOI Link to resource 10.1002/anie.201814471">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXosFKjtbk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30701650%5Buid%5D" title="PubMed Link to resource 30701650">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/14_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit15">Z. Yang, Y. Chen, L. Wan, Y. Li, D. Chen, J. Tao, P. Tang and F.-E. Chen, Iridium-Catalyzed Asymmetric, Complete Hydrogenation of Pyrimidinium Salts under Batch and Flow, <span class="italic">Green Chem.</span>, 2024, <span class="bold">26</span>(1), 317–322 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D3GC04364A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D3GC04364A">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/15_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit16">N. Mršić, T. Jerphagnon, A. J. Minnaard, B. L. Feringa and J. G. de Vries, Asymmetric Hydrogenation of Quinoxalines Catalyzed by Iridium/Pipphos, <span class="italic">Adv. Synth. Catal.</span>, 2009, <span class="bold">351</span>(16), 2549–2552 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adsc.200900522" title="DOI Link to resource 10.1002/adsc.200900522">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/16_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit17">W. Tang, L. Xu, Q. H. Fan, J. Wang, B. Fan, Z. Zhou, K. h. Lam and A. S. C. Chan, Asymmetric Hydrogenation of Quinoxalines with Diphosphinite Ligands: A Practical Synthesis of Enantioenriched, Substituted Tetrahydroquinoxalines, <span class="italic">Angew. Chem., Int. Ed.</span>, 2009, <span class="bold">48</span>(48), 9135–9138 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.200904518" title="DOI Link to resource 10.1002/anie.200904518">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXhsVahtb7E" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/17_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit18">A. Xu, C. Li, J. Huang, H. Pang, C. Zhao, L. Song, H. You, X. Zhang and F.-E. Chen, Highly Enantioselective Synthesis of Both Tetrahydroquinoxalines and Dihydroquinoxalinones Via Rh–Thiourea Catalyzed Asymmetric Hydrogenation, <span class="italic">Chem. Sci.</span>, 2023, <span class="bold">14</span>(34), 9024–9032 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D3SC00803G&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D3SC00803G">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/18_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit19">M. Rueping, F. Tato and F. R. Schoepke, The First General, Efficient and Highly Enantioselective Reduction of Quinoxalines and Quinoxalinones, <span class="italic">Chem.–Eur. J.</span>, 2010, <span class="bold">16</span>(9), 2688–2691 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/chem.200902907" title="DOI Link to resource 10.1002/chem.200902907">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXislKgurc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20140920%5Buid%5D" title="PubMed Link to resource 20140920">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/19_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit20">Q.-A. Chen, D.-S. Wang, Y.-G. Zhou, Y. Duan, H.-J. Fan, Y. Yang and Z. Zhang, Convergent Asymmetric Disproportionation Reactions: Metal/Brønsted Acid Relay Catalysis for Enantioselective Reduction of Quinoxalines, <span class="italic">J. Am. Chem. Soc.</span>, 2011, <span class="bold">133</span>(16), 6126–6129 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja200723n" title="DOI Link to resource 10.1021/ja200723n">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXkt1ylu7Y%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21466202%5Buid%5D" title="PubMed Link to resource 21466202">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/20_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit21">J. Qin, F. Chen, Z. Ding, Y. M. He, L. Xu and Q. H. Fan, Asymmetric Hydrogenation of 2- and 2,3-Substituted Quinoxalines with Chiral Cationic Ruthenium Diamine Catalysts<span class="bold">,</span>, <span class="italic">Org. Lett.</span>, 2011, <span class="bold">13</span>, 6568–6571 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol2029096" title="DOI Link to resource 10.1021/ol2029096">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2jtbvM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22098608%5Buid%5D" title="PubMed Link to resource 22098608">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/21_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit22">Z. Zhang and H. Du, A Highly Cis-Selective and Enantioselective Metal-Free Hydrogenation of 2,3-Disubstituted Quinoxalines, <span class="italic">Angew. Chem., Int. Ed.</span>, 2014, <span class="bold">127</span>(2), 633–636 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/ange.201409471" title="DOI Link to resource 10.1002/ange.201409471">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/22_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit23">C. Liu, X. Liu and Q. Liu, Stereodivergent Asymmetric Hydrogenation of Quinoxalines, <span class="italic">Chem</span>, 2023, <span class="bold">9</span>(9), 2585–2600 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3sXhtFamu7zF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/23_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit24">S. Fleischer, S. Zhou, S. Werkmeister, K. Junge and M. Beller, Cooperative Iron–Brønsted Acid Catalysis: Enantioselective Hydrogenation of Quinoxalines and 2 H-1,4-Benzoxazines, <span class="italic">Chem.–Eur. J.</span>, 2013, <span class="bold">19</span>(16), 4997–5003 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/chem.201204236" title="DOI Link to resource 10.1002/chem.201204236">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXjsVOis7c%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23463578%5Buid%5D" title="PubMed Link to resource 23463578">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/24_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit25">Z. Luo, Z. Li, H. Zhao, J. Yang, L. Xu, M. Lei, Q. Fan and P. J. Walsh, Borane-Catalyzed Tandem Cyclization/Hydrosilylation Towards Enantio- and Diastereoselective Construction of Trans-2,3 Disubstituted-1,2,3,4-Tetrahydroquinoxalines, <span class="italic">Angew. Chem., Int. Ed.</span>, 2023, <span class="bold">62</span>(32), e202305449 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.202305449" title="DOI Link to resource 10.1002/anie.202305449">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3sXhsVSqtLbO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/25_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit26">S. Alavi, M. H. Mosslemin, R. Mohebat and A. R. Massah, Green Synthesis of Novel Quinoxaline Sulfonamides with Antibacterial Activity, <span class="italic">Res. Chem. Intermed.</span>, 2017, <span class="bold">43</span>(8), 4549–4559 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s11164-017-2895-6" title="DOI Link to resource 10.1007/s11164-017-2895-6">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXjvVyis7g%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/26_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit27">M. Di Filippo and M. Baumann, Continuous Flow Synthesis of Quinolines Via a Scalable Tandem Photoisomerization-Cyclization Process, <span class="italic">Eur. J. Org Chem.</span>, 2020, <span class="bold">2020</span>(39), 6199–6211 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/ejoc.202000957" title="DOI Link to resource 10.1002/ejoc.202000957">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXhs1Klu7fK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/27_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit28">B. Borah and L. R. Chowhan, Recent Advances in the Transition-Metal-Free Synthesis of Quinoxalines, <span class="italic">RSC Adv.</span>, 2021, <span class="bold">11</span>(59), 37325–37353 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D1RA06942J&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D1RA06942J">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/28_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit29">Q. Zhao, J. Wen, R. Tan, K. Huang, P. Metola, R. Wang, E. V. Anslyn and X. Zhang, Rhodium-Catalyzed Asymmetric Hydrogenation of Unprotected Nh Imines Assisted by a Thiourea, <span class="italic">Angew. Chem., Int. Ed.</span>, 2014, <span class="bold">53</span>(32), 8467–8470 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201404570" title="DOI Link to resource 10.1002/anie.201404570">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShurnO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24939397%5Buid%5D" title="PubMed Link to resource 24939397">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/29_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit30">J. Wen, R. Tan, S. Liu, Q. Zhao and X. Zhang, Strong Brønsted Acid Promoted Asymmetric Hydrogenation of Isoquinolines and Quinolines Catalyzed by a Rh–Thiourea Chiral Phosphine Complex Via Anion Binding, <span class="italic">Chem. Sci.</span>, 2016, <span class="bold">7</span>(5), 3047–3051 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5SC04712A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5SC04712A">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/30_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit31">Z. Han, G. Liu, R. Wang, X.-Q. Dong and X. Zhang, Highly Efficient Ir-Catalyzed Asymmetric Hydrogenation of Benzoxazinones and Derivatives with a Brønsted Acid Cocatalyst, <span class="italic">Chem. Sci.</span>, 2019, <span class="bold">10</span>(15), 4328–4333 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C8SC05797D&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C8SC05797D">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/31_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit32">Z. Y. Han, G. Liu, X. L. Yang, X. Q. Dong and X. M. Zhang, Enantiodivergent Synthesis of Chiral Tetrahydroquinoline Derivatives Via Ir-Catalyzed Asymmetric Hydrogenation: Solvent-Dependent Enantioselective Control and Mechanistic Investigations, <span class="italic">ACS Catal.</span>, 2021, <span class="bold">11</span>, 7281–7291 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acscatal.1c01353" title="DOI Link to resource 10.1021/acscatal.1c01353">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXht1aktbjM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/32_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit33">M.-W. Chen, Z. Deng, Q. Yang, J. Huang and Y. Peng, Enantioselective Synthesis of Trifluoromethylated Dihydroquinoxalinones Via Palladium-Catalyzed Hydrogenation, <span class="italic">Org. Chem. Front.</span>, 2019, <span class="bold">6</span>(6), 746–750 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C8QO01361F&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C8QO01361F">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/33_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit34">P. T. Baraldi and V. Hessel, Micro Reactor and Flow Chemistry for Industrial Applications in Drug Discovery and Development<span class="bold">,</span>, <span class="italic">Green Process. Synth.</span>, 2012, <span class="bold">1</span>, 149–167 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXmtlemu7Y%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/34_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit35">P. D. Morse, R. L. Beingessner and T. F. Jamison, Enhanced Reaction Efficiency in Continuous Flow, <span class="italic">Isr. J. Chem.</span>, 2016, <span class="bold">57</span>(3–4), 218–227 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Isr.%20J.%20Chem.%5BJour%5D%20AND%2057%5Bvolume%5D%20AND%20218%5Bpage%5D%20and%202016%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/35_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit36">M. Baumann, T. S. Moody, M. Smyth and S. Wharry, A Perspective on Continuous Flow Chemistry in the Pharmaceutical Industry, <span class="italic">Org. Process Res. Dev.</span>, 2020, <span class="bold">24</span>(10), 1802–1813 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.oprd.9b00524" title="DOI Link to resource 10.1021/acs.oprd.9b00524">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXmtVGrtw%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/36_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit37">M. Guidi, P. H. Seeberger and K. Gilmore, How to Approach Flow Chemistry, <span class="italic">Chem. Soc. Rev.</span>, 2020, <span class="bold">49</span>(24), 8910–8932 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C9CS00832B&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C9CS00832B">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/37_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit38">J. Liao, X. Jia, F. Wu, J. Huang, G. Shen, H. You and F.-E. Chen, Rapid Mild Macrocyclization of Depsipeptides under Continuous Flow: Total Syntheses of Five Cyclodepsipeptides, <span class="italic">Org. Chem. Front.</span>, 2022, <span class="bold">9</span>(23), 6640–6645 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D2QO01577C&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D2QO01577C">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/38_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit39">J. Li, X. Song, Y. Wang, J. Huang, H. You and F.-E. Chen, Copper-Catalyzed Asymmetric Allylic Alkylation of Racemic Inert Cyclic Allylic Ethers under Batch and Flow Conditions, <span class="italic">Chem. Sci.</span>, 2023, <span class="bold">14</span>(16), 4351–4356 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D3SC00127J&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D3SC00127J">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/39_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit40">F. Guan, A. J. Blacker, B. Hall, N. Kapur, J. Wen and X. Zhang, High-Pressure Asymmetric Hydrogenation in a Customized Flow Reactor and Its Application in Multi-Step Flow Synthesis of Chiral Drugs, <span class="italic">J. Flow Chem.</span>, 2021, <span class="bold">11</span>(4), 763–772 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s41981-021-00143-8" title="DOI Link to resource 10.1007/s41981-021-00143-8">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXhsFegur7I" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/40_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit41">L. Xu, G. Wang, N. Rong, Y. Gu, L. A. Hu, H. You and Q. Yin, Enantioselective and Step-Economic Synthesis of the Chiral Amine Fragment in the Tyrosine Kinase Inhibitor Repotrectinib by Direct Asymmetric Reductive Amination under Batch and Flow, <span class="italic">Org. Process Res. Dev.</span>, 2023, 1539–1545 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Org.%20Process%20Res.%20Dev.%5BJour%5D%20AND%20%5Bvolume%5D%20AND%201539%5Bpage%5D%20and%202023%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/41_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit42">J. Li, X. Song, F. Wu, H. You and F. E. Chen, Copper-Catalyzed Asymmetric Allylic Alkylation of Racemic Cyclic Allyl Bromides with Organolithium Compounds, <span class="italic">Eur. J. Org Chem.</span>, 2022, <span class="bold">2022</span>(34), e202200860 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/ejoc.202200860" title="DOI Link to resource 10.1002/ejoc.202200860">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XitlyqsrnM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/42_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit43">D. Zhang, F. Wu, Z. Wan, Y. Wang, X. He, B. Guo, H. You and F.-E. Chen, A Palladium Polyaniline Complex: A Simple and Efficient Catalyst for Batch and Flow Suzuki–Miyaura Cross-Couplings, <span class="italic">Chem. Commun.</span>, 2022, <span class="bold">58</span>(77), 10845–10848 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D2CC04051D&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D2CC04051D">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/43_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit44">H. Pang, J. Huang, J. Wang, G. Wang, A. Xu, L. Luo, Q. Yuan, H. You and F.-E. Chen, Practical Synthesis of Tetrahydrofolate by Highly Efficient Catalytic Hydrogenation in Continuous Flow, <span class="italic">J. Flow Chem.</span>, 2024, <span class="bold">14</span>, 427–435 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s41981-024-00310-7" title="DOI Link to resource 10.1007/s41981-024-00310-7">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB2cXjvVarsr8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/44_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit45">T. Ayad, P. Phansavath and V. Ratovelomanana-Vidal, Transition-Metal-Catalyzed Asymmetric Hydrogenation and Transfer Hydrogenation: Sustainable Chemistry to Access Bioactive Molecules, <span class="italic">Chem. Rec.</span>, 2016, <span class="bold">16</span>(6), 2754–2771 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/tcr.201600100" title="DOI Link to resource 10.1002/tcr.201600100">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27699973%5Buid%5D" title="PubMed Link to resource 27699973">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/45_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit46">F. M. Bickelhaupt and K. N. Houk, Analyzing Reaction Rates with the Distortion/Interaction-Activation Strain Model, <span class="italic">Angew. Chem., Int. Ed.</span>, 2017, <span class="bold">56</span>(34), 10070–10086 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201701486" title="DOI Link to resource 10.1002/anie.201701486">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOlt7nL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/46_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit47">P. J. Dyson and P. G. Jessop, Solvent Effects in Catalysis: Rational Improvements of Catalysts Via Manipulation of Solvent Interactions, <span class="italic">Catal. Sci. Technol.</span>, 2016, <span class="bold">6</span>(10), 3302–3316 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5CY02197A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5CY02197A">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/47_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit48">T. Ishii, R. Watanabe, T. Moriya, H. Ohmiya, S. Mori and M. Sawamura, Cooperative Catalysis of Metal and O–H⋯O/Sp3–C–H⋯O
Two-Point Hydrogen Bonds in Alcoholic Solvents: Cu-Catalyzed Enantioselective Direct Alkynylation of Aldehydes with Terminal Alkynes, <span class="italic">Chem.–Eur. J.</span>, 2013, <span class="bold">19</span>(40), 13547–13553 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/chem.201301280" title="DOI Link to resource 10.1002/chem.201301280">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXht1yltrvL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23955688%5Buid%5D" title="PubMed Link to resource 23955688">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/48_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit49">S. Sakai, A. Fujioka, K. Imai, K. Uchiyama, Y. Shimizu, K. Higashida and M. Sawamura, Silver-Catalyzed Asymmetric Aldol Reaction of Isocyanoacetic Acid Derivatives Enabled by Cooperative Participation of Classical and Nonclassical Hydrogen Bonds, <span class="italic">Adv. Synth. Catal.</span>, 2022, <span class="bold">364</span>(14), 2333–2339 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adsc.202200327" title="DOI Link to resource 10.1002/adsc.202200327">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38Xhs1CltLzJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/49_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit50">W. Y. Tong, X. Su, P. Sun, S. Xu, S. Qu and X. Wang, Understanding the Reaction Mechanism of Ni-Catalyzed Regio- and Enantioselective Hydroalkylation of Enamines: Chemoselectivity of (Bi-Oxazoline)Nih, <span class="italic">J. Org. Chem.</span>, 2023, <span class="bold">88</span>(21), 15404–15413 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.joc.3c01939" title="DOI Link to resource 10.1021/acs.joc.3c01939">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3sXitFeqtb3P" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=37853516%5Buid%5D" title="PubMed Link to resource 37853516">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/50_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit51">S. Lan, H. Huang, W. Liu, C. Xu, X. Lei, W. Dong, J. Liu, S. Yang, A. E. Cotman, Q. Zhang and X. Fang, Asymmetric Transfer Hydrogenation of Cyclobutenediones, <span class="italic">J. Am. Chem. Soc.</span>, 2024, <span class="bold">146</span>(7), 4942–4957 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.3c14239" title="DOI Link to resource 10.1021/jacs.3c14239">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB2cXivFKmsrk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=38326715%5Buid%5D" title="PubMed Link to resource 38326715">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/51_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
      <li><span id="cit52">G. Liu, X. Yang, P. Gu, M. Wang, X. Zhang and X.-Q. Dong, Challenging Task of Ni-Catalyzed Highly Regio-/Enantioselective Semihydrogenation of Racemic Tetrasubstituted Allenes Via a Kinetic Resolution Process, <span class="italic">J. Am. Chem. Soc.</span>, 2024, <span class="bold">146</span>(11), 7419–7430 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.3c12597" title="DOI Link to resource 10.1021/jacs.3c12597">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB2cXltV2ju7g%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=38447583%5Buid%5D" title="PubMed Link to resource 38447583">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50003209/d4sc04222k/52_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50003209"/></a>.</span></li>
    </ol>
    
    
    
    
    
  <hr/><table><tr><td><h3>Footnote</h3></td></tr><tr><td><span class="sup_ref">† <span id="fn1">Electronic supplementary information (ESI) available. See DOI: <a target="_blank" href="https://doi.org/10.1039/d4sc04222k">https://doi.org/10.1039/d4sc04222k</a></span></span></td></tr></table><table><tr><td><hr/></td></tr><tr><td><b>This journal is © The Royal Society of Chemistry 2024</b></td></tr></table></div></div></div></body><script src="/content/scripts/CrossMarkIE.js"> </script><SaxonLicenceTest result="pass" message="Licenced Enterprise Edition [ EE 9.3.0.4 ]"/></html>